7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                
      operating activities
    		                
      net income
    		12,532,000 -6,645,000 -9,412,000 -708,000 -2,627,000 -19,421,000 -20,663,000 -30,376,000 -41,820,000 -41,489,000 -66,194,000 -132,747,000 -477,202,000 -72,418,000 -71,511,000 -76,330,000 
      less: net income from discontinued operations
    		122,000 -2,998,000 -2,803,000              
      net income from continuing operations
    		                
      adjustments to reconcile net income to net cash from operating activities:
    		                
      stock-based compensation
    		7,766,000 7,562,000 6,048,000 6,064,000 6,671,000 7,271,000 8,071,000 6,223,000 9,042,000 14,364,000 16,392,000 27,951,000 29,248,000 24,312,000 16,795,000 43,424,000 
      depreciation and amortization
    		1,041,000 640,000 407,000 486,000 681,000 558,000 564,000 608,000 600,000 626,000 630,000 929,000 4,623,000 4,601,000 3,842,000 5,111,000 
      amortization of deferred contract costs
    		429,000 431,000 315,000 289,000 260,000 253,000 266,000 552,000 682,000 761,000 984,000 1,133,000 1,183,000 1,244,000 1,174,000 1,245,000 
      amortization of debt discount and issuance costs
    		   0 0 170,000 520,000 689,000 790,000 759,000 730,000 747,000 731,000 709,000 706,000  
      amortization of operating lease right-of-use assets
    		151,000 122,000 77,000 196,000 631,000 842,000 861,000 846,000 835,000 809,000 806,000 1,025,000 851,000 785,000 956,000 1,116,000 
      accelerated amortization of right-of-use asset in connection with lease abandonment
    		   0             
      gain on investment in equity securities
    		   0 0 0 -4,417,000          
      loss on extinguishment of debt
    		   0 0            
      gain on sale of insurance business
    		   0             
      other
    		-39,000 -178,000 -138,000 -324,000 -359,000 -92,000 -234,000 -530,000 -1,285,000 -2,025,000 -1,347,000 501,000 410,000 1,049,000 1,628,000 487,000 
      changes in operating assets and liabilities:
    		                
      trade and other receivables
    		2,709,000 -4,270,000 3,906,000 -1,476,000 3,621,000 -1,409,000 182,000 1,245,000 1,709,000 -1,580,000 2,900,000 3,423,000 3,330,000 409,000 -3,778,000 -163,000 
      prepaid expenses and other assets, current and non-current
    		-3,447,000 -1,651,000 389,000 -857,000 -3,656,000 2,486,000 967,000 3,544,000 2,415,000 1,058,000 -4,969,000 -4,173,000 5,167,000 2,830,000 4,257,000 -11,282,000 
      deferred contract costs, non-current
    		263,000 -178,000 -353,000 -805,000 -43,000 177,000 256,000 -220,000 234,000 -993,000 217,000 701,000 669,000 852,000 -875,000 636,000 
      accounts payable
    		-429,000 -1,465,000 1,046,000 554,000 868,000 -1,217,000 -272,000 49,000 -1,028,000 1,217,000 672,000 -752,000 1,456,000 -4,314,000 -625,000 512,000 
      deferred revenue
    		-7,421,000 -520,000 13,254,000 -617,000 -975,000 -708,000 12,556,000 -1,072,000 -1,914,000 -1,076,000 4,351,000 -2,087,000 -2,126,000 6,104,000 -1,960,000 -1,450,000 
      accrued compensation
    		1,650,000 -1,195,000 511,000 -2,405,000 2,783,000 -1,961,000 -376,000 -4,305,000 5,126,000 -6,294,000 976,000 4,177,000 -3,913,000 -4,651,000 4,638,000 -422,000 
      operating lease liabilities
    		-712,000 -974,000 -947,000 -1,393,000 -1,046,000 -1,096,000 -1,050,000 -1,068,000 -1,027,000 -914,000 -1,003,000 -822,000 -883,000 -958,000 -1,049,000 -876,000 
      other liabilities, current and non-current
    		-524,000 31,000 2,179,000 -3,590,000 1,488,000 2,005,000 -1,099,000 -846,000 -246,000 387,000 -1,798,000 -5,464,000 -2,125,000 -3,532,000 -4,522,000 6,029,000 
      net cash from operating activities - continuing operations
    		-2,733,000 -5,292,000 20,085,000              
      net cash from operating activities - discontinued operations
    		-757,000 -1,076,000 305,000              
      net cash from operating activities
    		-3,490,000 -6,368,000 20,390,000 -4,586,000 2,076,000 -6,666,000 -3,868,000 -20,691,000 -25,887,000 -34,390,000 -46,653,000 -50,485,000 -46,758,000 -45,842,000 -43,124,000 -31,279,000 
      capex
    		52,000 -327,000 528,000 -264,000 0 0 0 0 0 0 0 -446,000 -896,000 -268,000 -649,000 -560,000 
      free cash flows
    		-3,438,000 -6,695,000 20,918,000 -4,850,000 2,076,000 -6,666,000 -3,868,000 -20,691,000 -25,887,000 -34,390,000 -46,653,000 -50,931,000 -47,654,000 -46,110,000 -43,773,000 -31,839,000 
      investing activities
    		                
      purchases of marketable securities
    		-6,741,000 -11,873,000 -11,876,000 -5,608,000 -19,893,000 -28,217,000 -48,312,000 -32,798,000 -8,324,000 -8,751,000 -186,206,000 -46,463,000 -19,305,000 -30,450,000 -34,764,000 -267,967,000 
      sale of available-for-sale securities
    		19,968,000 11,000 848,000 0 30,000 0 100,297,000          
      maturities of marketable securities
    		16,500,000 8,800,000 18,927,000 11,300,000 26,250,000 5,000,000 10,600,000 32,595,000 80,146,000 40,139,000 157,570,000 78,096,000 31,741,000 30,035,000 16,393,000 33,850,000 
      additions to property, equipment and internal-use software development costs
    		-2,272,000 -3,733,000 -4,587,000 -2,581,000             
      proceeds from sale of insurance business
    		   0             
      investment in non-marketable equity securities
    		0              0  
      net cash from investing activities - continuing operations
    		27,455,000 -10,795,000 3,312,000              
      net cash from investing activities - discontinued operations
    		-62,000 -36,000 -84,000              
      net cash from investing activities
    		  3,228,000 -1,889,000 11,747,000 -25,084,000 60,621,000 53,237,000 71,791,000 31,218,000 -28,940,000 31,187,000 11,540,000 -683,000 -19,172,000 -654,025,000 
      financing activities
    		                
      proceeds from exercises of stock options, including early exercises, net of repurchases
    		712,000 430,000 363,000 789,000 155,000 95,000 619,000 248,000 -2,000 1,000 21,000 940,000 428,000 1,202,000   
      taxes paid related to net share settlement of equity awards
    		-1,886,000 -2,531,000 -2,971,000 -7,112,000 -3,984,000 -3,213,000 -3,806,000 -1,314,000 -1,325,000 -1,092,000 -2,440,000      
      share repurchases
    		-5,025,000 -1,550,000 -2,568,000              
      repayment of long-term debt
    		   0 0            
      net proceeds from the issuance of the series a redeemable convertible preferred stock and the haveli warrant
    		                
      payment for issuance costs related to the series a redeemable convertible preferred stock and the haveli warrant
    		                
      net cash from financing activities - continuing operations
    		-6,199,000 -3,651,000 -5,176,000              
      effect of exchange rates on cash, cash equivalents, and restricted cash
    		   0 0 -1,000 -4,000  -23,000 5,000 8,000 55,000 77,000 28,000   
      net increase in cash, cash equivalents, and restricted cash
    		17,704,000 -20,850,000 18,442,000 -12,798,000 9,591,000 -39,071,000 53,562,000     -18,303,000 -34,983,000 -45,416,000 -63,230,000 -93,413,000 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 49,537,000 0 0 0 38,253,000 0 0 0 129,557,000 0 0 218,440,000 0 0 
      cash, cash equivalents, and restricted cash at end of period
    		17,704,000 -20,850,000 67,979,000 -12,798,000 9,591,000 -39,071,000 91,815,000 -53,596,000 44,554,000 -4,258,000 51,553,000 -18,303,000 -34,983,000 173,024,000 -63,230,000 -93,413,000 
      less: cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations
    		-818,000 -1,105,000 6,712,000              
      cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations
    		18,522,000 -19,745,000 61,267,000              
      reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets:
    		                
      cash and cash equivalents
    		18,522,000 -19,745,000 56,244,000 -12,798,000 9,591,000 -39,071,000 84,521,000 -53,593,000 49,575,000 -11,215,000 46,195,000 -18,303,000 -34,983,000 167,666,000 -62,981,000 -93,663,000 
      restricted cash
    		0 0 5,023,000 0 0 0 7,294,000 -3,000 -5,021,000 6,957,000 5,358,000 0 0 5,358,000 -249,000 250,000 
      total cash, cash equivalents, and restricted cash
    		18,522,000 -19,745,000 61,267,000 -12,798,000 9,591,000 -39,071,000 91,815,000 -53,596,000 44,554,000 -4,258,000 51,553,000 -18,303,000 -34,983,000 173,024,000 -63,230,000 -93,413,000 
      supplemental disclosure of cash flow information:
    		                
      cash paid for income taxes
    		-132,000 199,000 133,000 0 0 67,000 9,000  0 -53,000 101,000   11,000 394,000 445,000 
      cash paid for interest
    		   0 0 1,621,000 4,529,000  7,364,000 7,189,000 6,911,000   4,944,000   
      supplemental disclosure of non-cash investing and financing activities:
    		                
      reclassification of redeemable noncontrolling interest related to discontinued operations to equity
    		0 0 52,675,000              
      vesting of early exercised stock options
    		   0 7,000 172,000 184,000  230,000 256,000 758,000   1,913,000 1,677,000 1,809,000 
      operating lease liabilities arising from obtaining new or modified right-of-use assets
    		-56,000   0 497,000 0 654,000  0 0 327,000      
      stock-based compensation included in capitalized internal-use software development costs
    		592,000 1,127,000 1,218,000 509,000 811,000 494,000 636,000          
      accretion of redeemable noncontrolling interest related to discontinued operations to redemption value
    		0 0 1,254,000              
      accretion of series a redeemable convertible preferred stock to redemption value
    		4,558,000 4,376,000 4,202,000 4,170,000 4,048,000            
      covered warrant received in connection with strategic partnership and sale of insurance business
    		                
      accrual of transaction costs incurred in connection with sale of insurance business
    		                
      capitalized internal-use software development costs included in accrued compensation
    		52,000 -327,000 528,000 -264,000             
      income from continuing operations
    		 -3,647,000 -6,609,000              
      net cash provided (used in) by investing activities
    		                
      issuance costs accrued in connection with the series a redeemable convertible preferred stock and the warrant
    		                
      impairment of intangible assets and goodwill
    		           57,857,000     
      release of valuation allowance and change in deferred taxes
    		           0 0 -2,864,000 7,200,000 0 
      investment in note receivable
    		              0  
      proceeds from initial public offering, net of underwriters' fees and issuance costs
    		              -2,048,000  
      net cash from financing activities
    		   -6,323,000 -4,232,000 -7,320,000 -3,187,000 -86,121,000 -1,327,000 -1,091,000 -2,419,000 940,000 158,000 1,081,000 -925,000 591,891,000 
      reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets:
    		                
      accretion of redeemable noncontrolling interest to redemption value
    		   1,511,000 1,760,000 1,527,000 1,461,000  1,452,000 1,592,000 2,056,000   1,442,000   
      net proceeds from the issuance of the series a redeemable convertible preferred stock and the warrant
    		    0            
      payment for issuance costs related to the series a redeemable convertible preferred stock and the warrant
    		    -403,000            
      warrant received in connection with strategic partnership and sale of insurance business
    		                
      additions to property, equipment, internal-use software development costs and intangible assets
    		     -1,867,000 -1,964,000          
      sale of marketable securities
    		                
      additions to property, equipment, internal-use software and intangible assets
    		       -82,000 -31,000 -170,000 -304,000      
      acquisition of title365, net of cash acquired
    		              0  
      proceeds from debt financing, net of issuance costs
    		              -24,000  
      partial repayment of long-term debt principal
    		                
      proceeds from issuance of convertible preferred stock, net of issuance costs
    		              0 0 
      proceeds from exercises of convertible preferred stock warrants
    		              0 0 
      proceeds from repayment of employee promissory note collateralized by common stock
    		              0  
      effect of exchange rates on cash, cash equivalents and restricted cash
    		                
      payment of initial public offering costs
    		            -270,000 -121,000   
      net decrease in cash, cash equivalents, and restricted cash
    		        44,554,000 -4,258,000 -78,004,000      
      purchases of property and equipment
    		           -446,000 -896,000 -268,000 -649,000 -560,000 
      purchase of other investment
    		                
      cash acquired in connection with business combination
    		                
      payment of debt issuance costs
    		                
      right-of-use assets obtained in exchange for lease obligations
    		             317,000   
      interest on discount on convertible note
    		                
      sales of marketable securities
    		                
      capitalization of internal-use software
    		                
      purchases of intangible assets
    		                
      repurchases of unvested early exercised stock options
    		              -110,000 -10,000 
      proceeds from exercises of stock options, including early exercises
    		              1,257,000 708,000 
      proceeds from exercises of common stock warrants
    		                
      proceeds from convertible debt
    		                
      proceeds from exercises of series d convertible preferred stock warrants
    		                
      non-cash additions to property and equipment
    		                
      issuance of warrant in connection with debt financing
    		              0  
      exercise of series d convertible preferred stock warrants included in prepaid expenses and other current assets
    		                
      deferred offering costs not yet paid
    		               -2,661,000 
      payment of deferred offering costs
    		                
      repayment of employee promissory note collateralized by common stock
    		                
      acquisition cash consideration not yet paid
    		                
      additions of property and equipment included in accrued expenses
    		                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.